98%
921
2 minutes
20
Cardiovascular and metabolic dysfunction plays a significant role in the onset and progression of inflammation and cerebrovascular diseases, often leading to cognitive impairment. While growing evidence highlights the link between activity in key brain regions and cardiovascular disease events, the relationship between brain dynamics and cardiovascular or metabolic profiles in healthy individuals remains largely unexplored. We performed magnetoencephalography (MEG) in 29 healthy participants (12 males and 17 females; aged 19-72). Brain activity calculated as neural activity index (NAI) was determined in 15 regions of interest in each participant. Brachial and central blood pressure (BP), arterial stiffness and metabolic profile were assessed. Brachial diastolic BP correlated positively with NAI in right parahippocampal gyrus, insula and amygdala (across several frequency bands) while both central systolic and diastolic BP correlated positively with NAI in left orbitofrontal cortex (theta and alpha bands). Arterial stiffness measured via augmentation index correlated negatively with NAI in left and right medial prefrontal cortex (delta and high-gamma bands), while pulse wave velocity correlated positively with left caudate (theta and alpha bands). NAI in several brain regions showed associations with metabolic parameters (lipid levels, kidney function, liver proteins) including middle frontal gyrus, anterior cingulate gyrus, lateral occipital cortex, precuneus, insula, parahippocampal gyrus, hippocampus, amygdala, putamen and thalamus (across several frequency bands). We have shown activity in key brain regions correlated with cardiovascular and metabolic profile in healthy individuals suggesting that regions involved in cognitive and emotional processing may be influenced by or contribute to cardiovascular and metabolic health.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1152/jn.00114.2025 | DOI Listing |
ESC Heart Fail
September 2025
Department of Clinical and Molecular Medicine, Sapienza University, Rome, Italy.
Heart failure (HF) is a multifactorial and pathophysiological complex syndrome, involving not only neurohormonal activation but also oxidative stress, chronic low-grade inflammation, and metabolic derangements. Central to the cellular defence against oxidative damage is nuclear factor erythroid 2-related factor 2 (Nrf2), a transcription factor that orchestrates antioxidant and cytoprotective responses. Preclinical in vitro and in vivo studies reveal that Nrf2 signalling is consistently impaired in HF, contributing to the progression of myocardial dysfunction.
View Article and Find Full Text PDFCurr Opin Lipidol
August 2025
Cardiometabolic Immunity Laboratory, Department of Physiology, Monash Biomedicine Discovery Institute (BDI) and Victorian Heart Institute (VHI), Monash University, Melbourne, Victoria, Australia.
Purpose Of Review: This review explores the evolving understanding of efferocytosis - the clearance of dead or dying cells by phagocytes - in the context of atherosclerosis. It highlights recent discovers in cell death modalities, impaired clearance mechanisms and emerging therapeutic strategies aimed at restoring efferocytosis to stabilize plaques and resolve inflammation.
Recent Findings: Recent studies have expanded the scope of efferocytosis beyond apoptotic cells to include other pro-inflammatory cell death modes, including pyroptosis, necroptosis and ferroptosis, revealing context-dependent clearance efficiency and immunological outcomes.
Zhong Nan Da Xue Xue Bao Yi Xue Ban
May 2025
Department of Rheumatology and Immunology, Xiangya Hospital, Central South University, Changsha 410008.
Objectives: Patients with connective tissue diseases (CTD) have a high incidence of cardiac involvement, which often presents insidiously and can progress rapidly, making it one of the leading causes of death. Multiparametric cardiovascular magnetic resonance (CMR) provides a comprehensive quantitative evaluation of myocardial injury and is emerging as a valuable tool for detecting cardiac involvement in CTD. This study aims to investigate the correlations between CMR features and serological biomarkers in CTD patients, assess their potential clinical value, and further explore the impact of pre-CMR immunotherapy intensity on CMR-specific parameters, thereby evaluating the role of CMR in the early diagnosis of CTD-related cardiac involvement.
View Article and Find Full Text PDFZhong Nan Da Xue Xue Bao Yi Xue Ban
May 2025
Department of Hepatobiliary and Pancreatic Surgery, Third Xiangya Hospital, Central South University, Changsha 410013, China.
Objectives: In recent years, the role of remnant cholesterol (RC) in the development and progression of cardiovascular diseases has gained increasing attention. However, evidence on the association between RC and subclinical atherosclerosis is limited. This study aims to examine the relationship between RC and atherosclerotic plaques in single and multiple vascular territories.
View Article and Find Full Text PDFEur J Heart Fail
September 2025
Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Aims: The estimated glucose disposal rate (eGDR) is a simple, non-invasive measure of insulin resistance. In this exploratory analysis of FINEARTS-HF, we evaluated whether lower eGDR, reflecting greater insulin resistance, is associated with adverse outcomes in heart failure (HF).
Methods And Results: The eGDR was calculated at baseline using waist circumference, glycated haemoglobin, and hypertension status.